Video Games Can Cause More Than Virtual Eyestrain, According To The Minnesota Optometric Association
When video game enthusiasts become engrossed in the game, their eyes are glued to the screen. The Minnesota Optometric Association (MOA) says that gamers of all ages often suffer from Computer Vision Syndrome (CVS). Without giving up the hugely popular pastime, players can avoid eyestrain and other symptoms of CVS.
RegenRx Biopharmaceuticals (Bethesda, Md.) has been granted a patent by the Hong Kong Intellectual Property Department for the use of Tβ4 analogues, isoforms, and derivatives “to accelerate corneal wound healing and reverse or inhibit eye degeneration,” the company said in a press release. Tβ4’s corneal wound healing capabilities are being investigated in a Phase II trial. This trial is evaluating the use of an ophthalmic formulation, RGN-259, in diabetic vitrectomy patients. Tβ4 is a synthetic version of a naturally occurring human peptide, and promotes endothelial cell differentiation, angiogenesis in dermal tissues, keratinocyte migration, collagen deposition, and the down-regulation of inflammation.
Links to drug information on the AbstractPlus display to MedMaster Patient Drug Information, a new book available on the Bookshelf, are now available for all PubMed users.
A Genetic Marker For Nearsightedness? Update On Vitamins And AMD, And Recovery From Optic Neuritis
The June 2008 issue of Ophthalmology, the journal of the American Academy of Ophthalmology, includes a groundbreaking study on genetic factors and nearsightedness, a cautionary tale on age-related macular degeneration (AMD) patients' vitamin use, and good news for people who have had an acute attack of optic neuritis. Strong Evidence for a Genetic Marker for Nearsightedness Research by Gu Zhu, M.D.
The diabetes medication rosiglitazone has been associated with areduction in the likelihood of developing the eye disease calledproliferative diabetic retinopathy. A study published in the June issueof Archives of Ophthalmology also found thatdiabetes patients using the drug were less likely to have reductions invisual acuity (or sharpness).
Allergan Receives U.S. Food And Drug Administration Approval For TRIVARIS? (triamcinolone Acetonide Injectable Suspension) 80 Mg/mL
Allergan, Inc. (NYSE: AGN) announced that the U.S. Food and Drug Administration (FDA) has approved TRIVARIS? (triamcinolone acetonide injectable suspension) 80 mg/mL, a synthetic glucocorticoid corticosteroid with anti-inflammatory action. Delivered via intravitreal injection, the ophthalmic indications for TRIVARIS? include sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.
Technique good for detecting, classifying glaucomatous optic neuropathy vision loss
Evaluating retinal asymmetry using pupillometry can rapidly detect and classify visual field defects caused by glaucomatous optic neuropathy, a small study suggests.
